Het Regionaal Ziekenhuis Heilig Hart Tienen is een regionaal katholiek ziekenhuis, met campussen in de Belgische steden Tienen en Aarschot.

During the past decade, Regionaal Ziekenhuis Heilig Hart Tienen conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 5 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regionaal Ziekenhuis Heilig Hart Tienen" #1 sponsor was "Flanders Medical Research Program" with 12 trials, followed by "Boston Scientific Corporation" with 6 trials sponsored, "ID3 Medical" with 5 trials sponsored, "Biotronik AG" with 3 trials sponsored and "Contego Medical, Inc." with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regionaal Ziekenhuis Heilig Hart Tienen" #1 collaborator was "Biotronik, Inc." with 1 trials as a collaborator, "Genae" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "Novella Clinical" with 1 trials as a collaborator and "Sint-Trudo Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Regionaal Ziekenhuis Heilig Hart Tienen" are "Peripheral Arterial Disease" (15 trials), "Peripheral Vascular Disease" (7 trials), "Peripheral Artery Disease" (5 trials), "Atherosclerosis" (4 trials) and "Arterial Occlusive Diseases" (2 trials). Many other conditions were trialed in "Regionaal Ziekenhuis Heilig Hart Tienen" in a lesser frequency.

Most popular intervention types in "Regionaal Ziekenhuis Heilig Hart Tienen" are "Device" (31 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Peripheral stenting" (2 trials), "Akesys Prava Scaffold" (1 trials), "Astron/Pulsar-18 stent" (1 trials), "Ballon expandable stent and PTA" (1 trials) and "BeGraft Peripheral Plus Stent Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regionaal Ziekenhuis Heilig Hart Tienen" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Regionaal Ziekenhuis Heilig Hart Tienen". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Regionaal Ziekenhuis Heilig Hart Tienen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regionaal Ziekenhuis Heilig Hart Tienen, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 15 trials that are defined as “Not Applicable".